Celcuity's gedatolisib, a dual PI3K/mTOR inhibitor, shows promise in Phase 3 breast cancer trials. Click here to read an ...

Hepatocellular carcinoma (HCC) is one of the deadliest cancers globally, with increasing incidence and mortality rates.

Hepatocellular carcinoma (HCC) is one of the deadliest malignant tumors in the world, and its incidence and mortality have ...

Researchers developed a coordination nanomedicine (ZnDHT NM) that targets tumor cells and cancer stem-like cells, enhancing ...

Tumor metastasis, recurrence, and therapeutic resistance are the main reasons for the failure of clinical cancer treatment. Studies have found that ...

In a paper published in National Science Review, an international team of scientists report a coordination nanomedicine ...

CIRBP Family, Tumors, Molecular Mechanisms, RNA-Binding Proteins, Cellular Stress Share and Cite: Cai, Y. , Wang, T. and Zhan ...

Prostate cancer has a tendency to spread to the bones, specifically the pelvis, upper legs, and lower spine. While those are the most common sites for prostate cancer bone metastasis, any bones in ...

In this review, we shall dissect the crosstalk between the coagulation cascade and autophagic pathway and its possible role in metastasis and cancer-associated thrombosis formation. The signaling of ...

Metastatic progression is the deadliest feature of cancer. Cancer cell growth, invasion, intravasation, circulation, arrest/adhesion and extravasation require specific mechanical properties to allow ...

9 Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China Objective Metastasis is the major cause of cancer death. However, what types of heterogenous cancer cells ...

Correspondence to Professor Ji-Hun Mo, Otorhinolaryngology, Dankook University College of Medicine, Cheonan, Chungcheongnam-do, South Korea; jihunmo{at}gmail.com; Professor Hyun-Woo Shin, Pharmacology ...